thisdrug what a medicine's name tells you

WHO naming stem · suffix · 19 listed names

-ertinib

epidermal growth factor receptor (EGFR) inhibitors

WHO's definition, quoted as written in the 2024 stem book
Names only. This page is about -ertinib as a part of a name. It has nothing on uses, doses, side effects or interactions of any medicine that carries it, and nothing here is medical advice. Ask a pharmacist or doctor about the medicine itself.

Where it sits in a name

WHO writes the stem as -ertinib. So the letters ertinib sit at the end of the name (…ertinib).

All 19 names WHO lists under -ertinib

These are the INN in group (a) of Part IV of the stem book: names in which WHO says the stem is used as defined. The stem is marked where WHO places it. A-Z as WHO lists them.

  1. abivertinib
  2. aumolertinib
  3. befotertinib
  4. canertinib
  5. epertinib
  6. lazertinib
  7. mavelertinib
  8. mifanertinib
  9. mobocertinib
  10. olafertinib
  11. osimertinib
  12. rezivertinib
  13. sacibertinib
  14. sunvozertinib
  15. tuxobertinib
  16. xiliertinib
  17. zipalertinib
  18. zongertinib
  19. zorifertinib

Decode another name

Decoded

epertinib

Listed INNCarries 2 WHO stems, most specific first: -ertinib …

  • -ertinibend of the nameWHO lists it hereWHO definition: epidermal growth factor receptor (EGFR) inhibitors
  • -tinibend of the nameWHO lists it hereWHO definition: tyrosine kinase inhibitors

“epertinib” is an INN that WHO lists under -ertinib, -tinib in the 2024 stem book.

The same decoder as the front page: it reads the letters of a name against all 482 WHO stems, in your browser.

Source and licence

The definition of -ertinib (Part II B) and the 19 names (Part IV, group (a)) are from Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024 (World Health Organization, Stem book 2024 (ISBN 978-92-4-009938-8); covers proposed INN Lists 1-129). Checked .

Adapted from: Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO. This adaptation was not created by WHO; WHO is not responsible for its content or accuracy and does not endorse this site. The data file stems.json is shared under the same licence.